Submitted by Anonymous (not verified) on 10 February 2026 - 13:20
Human medicines European public assessment report (EPAR): Imfinzi, durvalumab, Date of authorisation: 21/09/2018, Revision: 26, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Imfinzi, durvalumab, Date of authorisation: 21/09/2018, Revision: 26, Status: Authorised